A Phase Ib Trial of Intravesical Photodynamic Therapy in Patients With Non-muscle Invasive Bladder Cancer at High Risk of Progression Who Are Refractory to Bacillus Calmette-Guerin Therapy and Who Are Medically Unfit for/Refuse Cystectomy
Phase of Trial: Phase I
Latest Information Update: 24 Aug 2018
Price : $35 *
At a glance
- Drugs TLD 1433 (Primary)
- Indications Bladder cancer
- Focus Adverse reactions
- Sponsors Theralase Technologies
- 17 Aug 2018 Status changed from recruiting to completed.
- 18 Apr 2018 Planned End Date changed from 1 Dec 2017 to 30 Sep 2018.
- 18 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 30 Sep 2018.